Postavke privatnosti

Advances in safer analgesics: a new compound from the sea fungus Aspergillus nidulans can replace opioids without side effects

Researchers at the Johannes Gutenberg University of Mainz have discovered the natural compound aniquinazolin B from the sea fungus Aspergillus nidulans that stimulates opioid receptors and could be used in place of opioids, reducing the risk of addiction and serious side effects.

Advances in safer analgesics: a new compound from the sea fungus Aspergillus nidulans can replace opioids without side effects
Photo by: Domagoj Skledar/ arhiva (vlastita)

Opioids have long been recognized as natural substances with significant pharmacological effects. They are used as analgesics to relieve pain, and morphine, which was isolated and synthesized in the early 19th century, is one of the most well-known examples. This substance provides relief for severely ill patients in the terminal stages of disease. However, improper use of opioids can lead to addiction and serious adverse effects such as respiratory depression.

In the USA, opioids were once heavily promoted through the media, resulting in frequent prescriptions for mild health issues. According to the Centers for Disease Control and Prevention (CDC), nearly 645,000 opioid overdose deaths were recorded in the USA between 1999 and 2021. The opioid crisis has also reached Germany, where the main problem is street drugs, especially heroin, which is often mixed with cheaper opioids like fentanyl. While the lethal dose of heroin is 200 milligrams, just two milligrams of fentanyl can be fatal. In 2022, more than 1,000 people in Germany died due to opioid consumption.

Beginning research with a database of 40,000 natural substances
Governments have introduced measures to combat this epidemic, but the rate of opioid addiction remains high. Meanwhile, many suffer from severe pain that needs to be alleviated. Therefore, there is an urgent need for safe analgesics. Researchers from Johannes Gutenberg University Mainz (JGU), with financial support from the Research Training "Life Sciences – Life Writing" funded by the German Research Foundation (DFG), have made progress towards this goal. "The natural product aniquinazoline B, isolated from the marine fungus Aspergillus nidulans, stimulates opioid receptors and could be used instead of opioids in the future," explained Roxana Damiescu, a member of the research team led by Professor Thomas Efferth. 

Detailed laboratory research
In the search for new compounds, the team started with a chemical database containing more than 40,000 natural substances. The goal was to determine how effectively each substance binds to the corresponding receptor, and also to establish whether these substances have the properties needed for a pharmaceutical drug. Compounds must be somewhat water-soluble, for example. This research required computational calculations in the form of approximations, with results becoming more precise as the number of calculations increased. Each substance was subjected to around 750,000 individual calculations. Such a large number of calculations would far exceed the capacity of a standard computer, so the team used the MOGON supercomputer at JGU. The top 100 candidates from these calculations were then assessed using other analytical methods. 

Further research in the laboratory
The resulting ten best compounds underwent laboratory analysis, where they were subjected to biochemical analysis. The first priority was to determine safety. Using preparations of human kidney cells, researchers checked whether a higher concentration of each substance is toxic to the cells and can kill them. Finally, two other aspects also needed to be tested. "We needed to confirm that the high binding energy of the substance to pain receptors, which was predicted by theoretical calculations, actually exists in the real physical world," said Professor Thomas Efferth, head of the Department of Pharmaceutical Biology at JGU. However, binding of the substance to the receptors is not sufficient by itself. The binding must also affect the functionality of the receptors. Therefore, the research team used a second test system to assess the inhibition of biological activity that occurs with the use of opioids. One of the two compounds passed all tests: aniquinazoline B, a substance present in the marine fungus Aspergillus nidulans. "Our research results show that this substance can have similar effects as opioids, but with significantly fewer adverse reactions," concluded Roxana Damiescu. 

The research work was recently published in the journal ChemMedChem.

Source: Johannes Gutenberg-Universität Mainz

Find accommodation nearby

Creation time: 19 July, 2024

Science & tech desk

Our Science and Technology Editorial Desk was born from a long-standing passion for exploring, interpreting, and bringing complex topics closer to everyday readers. It is written by employees and volunteers who have followed the development of science and technological innovation for decades, from laboratory discoveries to solutions that change daily life. Although we write in the plural, every article is authored by a real person with extensive editorial and journalistic experience, and deep respect for facts and verifiable information.

Our editorial team bases its work on the belief that science is strongest when it is accessible to everyone. That is why we strive for clarity, precision, and readability, without oversimplifying in a way that would compromise the quality of the content. We often spend hours studying research papers, technical documents, and expert sources in order to present each topic in a way that will interest rather than burden the reader. In every article, we aim to connect scientific insights with real life, showing how ideas from research centres, universities, and technology labs shape the world around us.

Our long experience in journalism allows us to recognize what is truly important for the reader, whether it is progress in artificial intelligence, medical breakthroughs, energy solutions, space missions, or devices that enter our everyday lives before we even imagine their possibilities. Our view of technology is not purely technical; we are also interested in the human stories behind major advances – researchers who spend years completing projects, engineers who turn ideas into functional systems, and visionaries who push the boundaries of what is possible.

A strong sense of responsibility guides our work as well. We want readers to trust the information we provide, so we verify sources, compare data, and avoid rushing to publish when something is not fully clear. Trust is built more slowly than news is written, but we believe that only such journalism has lasting value.

To us, technology is more than devices, and science is more than theory. These are fields that drive progress, shape society, and create new opportunities for everyone who wants to understand how the world works today and where it is heading tomorrow. That is why we approach every topic with seriousness but also with curiosity, because curiosity opens the door to the best stories.

Our mission is to bring readers closer to a world that is changing faster than ever before, with the conviction that quality journalism can be a bridge between experts, innovators, and all those who want to understand what happens behind the headlines. In this we see our true task: to transform the complex into the understandable, the distant into the familiar, and the unknown into the inspiring.

NOTE FOR OUR READERS
Karlobag.eu provides news, analyses and information on global events and topics of interest to readers worldwide. All published information is for informational purposes only.
We emphasize that we are not experts in scientific, medical, financial or legal fields. Therefore, before making any decisions based on the information from our portal, we recommend that you consult with qualified experts.
Karlobag.eu may contain links to external third-party sites, including affiliate links and sponsored content. If you purchase a product or service through these links, we may earn a commission. We have no control over the content or policies of these sites and assume no responsibility for their accuracy, availability or any transactions conducted through them.
If we publish information about events or ticket sales, please note that we do not sell tickets either directly or via intermediaries. Our portal solely informs readers about events and purchasing opportunities through external sales platforms. We connect readers with partners offering ticket sales services, but do not guarantee their availability, prices or purchase conditions. All ticket information is obtained from third parties and may be subject to change without prior notice. We recommend that you thoroughly check the sales conditions with the selected partner before any purchase, as the Karlobag.eu portal does not assume responsibility for transactions or ticket sale conditions.
All information on our portal is subject to change without prior notice. By using this portal, you agree to read the content at your own risk.